Low prevalence of biliary tract cancer with defective mismatch repair genes in a Japanese hospital‑based population-Reference-Cited by-同舟云学术

Low prevalence of biliary tract cancer with defective mismatch repair genes in a Japanese hospital‑based population

Published:2021-11-04 Issue:1 Volume:23 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Ando Yasuhisa¹,Kumamoto Kensuke¹,Matsukawa Hiroyuki¹,Ishikawa Ryou²,Suto Hironobu¹,Oshima Minoru¹,Kamada Hideki³,Morishita Asahiro³,Kobara Hideki³,Matsunaga Toru²,Haba Reiji²,Masaki Tsutomu³,Suzuki Yasuyuki¹,Okano Keiichi¹

Affiliation:

1. Department of Gastroenterological Surgery, Kagawa University, Miki, Kagawa 761‑0793, Japan

2. Department of Diagnostic Pathology, Kagawa University, Miki, Kagawa 761‑0793, Japan

3. Department of Gastroenterology and Neurology, Kagawa University, Miki, Kagawa 761‑0793, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The biliary tree musketeers: cholangiocarcinoma – one name for all, but at least three different diseases with distinct targets;Surgical and Experimental Pathology;2024-08-20

2. Targeted Therapies in Advanced Cholangiocarcinoma;Life;2023-10-16

3. Lacking Immunotherapy Biomarkers for Biliary Tract Cancer: A Comprehensive Systematic Literature Review and Meta-Analysis;Cells;2023-08-19

4. Discordant microsatellite instability findings in two samples from a patient with biliary cancer that responded to pembrolizumab;Clinical Journal of Gastroenterology;2023-07-25

5. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial;The Lancet;2023-06